For much of the 20th century, a company known as Union Minière du Haut Katanga exploited the rich mineral resources of Belgium’s
Don’t ask Novo Nordisk for the company’s corporate responsibility report. The Danish pharmaceutical firm, which had revenues of DKK 60.7 billion (US$10.5